We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...
GSK's liquid meningitis vaccine, Menveo, received approval from the European Commission to be sold in the European Union. The British pharmaceutical company said Wednesday that the fully liquid ...
GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...
In this Q&A, He discussed Boehringer's investments in AI as well as areas where the technology could deliver greater value for pharma.
MDCX READ THE FULL V.MDCX RESEARCH REPORT IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq On ...
In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.90. The company’s shares opened today at ...
Big Pharma allows millions of people to alleviate debilitating pain, manage dangerous and chronic diseases, mitigate their ...
GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...
CVS Pharmacy is facing a proposed class-action lawsuit alleging that it misleadingly markets certain over-the-counter medications as "non-drowsy" despite t ...
The global over-the-counter (OTC) pain medication market is poised for steady growth, with its market size expected to attain ...
Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health ...
Zacks.com on MSN11d
Incyte Pauses Enrollment in Chronic Spontaneous Urticaria StudyIncyte INCY suffered a setback in its ongoing mid-stage study on MRGPRX2 (INCB000262) in chronic spontaneous urticaria (CSU).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback